BU (Defiance Daily Target 2X Long B ETF) is no longer actively trading.
This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

The Defiance Daily Target 2X Long BU ETF (BU) is engineered to deliver amplified returns, specifically two times (200%) the daily percentage change of Barrick Mining Corporation (NYSE: B) shares. Barrick Mining is a major player in gold and copper production, as well as exploration and mining development. This objective is achieved through the use of swap agreements and daily rebalancing to consistently target this leveraged exposure. As a leveraged financial instrument, BU is explicitly structured for short-term, tactical trading rather than functioning as a long-term investment vehicle…
Is BU's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Dallas, Texas--(Newsfile Corp. - August 13, 2026) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). Burcon's 1Q27 results reinforce the transition from technology validation to commercial execution.

Dallas, Texas--(Newsfile Corp. - June 26, 2026) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). Burcon has moved from commissioning and into early utilization, with growing customer volume setting up better fixed-cost absorption at Galesburg.

Vancouver, British Columbia--(Newsfile Corp. - June 19, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, will hold an investor conference call and webcast on Wednesday, June 24, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal year ended March 31, 2026.

Advancing Burcon's commercialization journey through growing commercial traction and manufacturing scale Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based proteins, today announced continued commercial and operational momentum, highlighted by strong growth in sales compared to the previous quarter and the establishment of a new production record with its manufacturing partner, marking another milestone in Burcon's transition from technology development to commercial-scale ingredient sales. "Approximately 50% growth in sales compared to the previous quarter, combined with record production performance, reflects the continued transition of Burcon from technology development to commercial-scale ingredient sales," said Kip Underwood, Chief Executive Officer of Burcon.

NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Tidal Financial Group and Defiance ETFs today announced their decision to close and liquidate two exchange-traded funds: the Defiance Daily Target 2X Long B ETF (Nasdaq: BU), and the Defiance Daily Target 2X Long CVNA ETF (Nasdaq: CVNX). The final day of trading for BU and CVNX (the “funds”) on the Nasdaq will be Monday, June 8, 2026.